Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The treatment successfully lowered testosterone levels and reduced symptoms.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone therapy may help women with low sexual desire after surgical menopause.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

A man developed hair loss from testosterone treatment but improved with additional medication.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Dogs exposed to their owners' hormone therapy developed hair loss, but symptoms resolved after stopping the therapy.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Oral testosterone therapy raises heart risk more than other methods.

Individuals with male pseudohermaphroditism often do better raised as females with early surgery.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.